Literature DB >> 14607617

Cytomegalovirus glycoprotein B sequence variation in Chinese liver transplant recipients.

Shu-Sen Zheng1, Lin Zhou, Jing Qian, Ting Cai, Jun Fan, Wei-Hang Ma.   

Abstract

OBJECTIVE: To investigate human cytomegalovirus infection and genetic variations in glycoprotein B (gB) in liver transplant recipients in south-east China.
METHODS: EDTA-blood samples were obtained from 21 liver transplant recipients. The semi-nested PCR was used to amplify a region of high sequence variability in the gB gene of human cytomegalovirus (HCMV) followed by direct sequence analysis.
RESULTS: Out of the 21 liver transplant recipients, 5 were proved HCMV positive 62 to 180 days after transplantation. The nucleotide and encoded amino acid sequences were compared with published sequences of AD169 and Towne laboratory strains. Within the region sequenced, 2 out of 5 strains possessed a peptide configuration similar to that of strain AD169, while another 2 strains displayed a peptide configuration similar to that of strain Towne. One strain had amino acid substitution, which was different from those of both AD169 and Towne in the cleavage site.
CONCLUSION: Our results provide molecular epidemiological data for HCMV strains circulating among transplant recipients in south-east China.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14607617

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  2 in total

1.  Positively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency.

Authors:  Lucas M Stangherlin; Felipe N de Paula; Marcelo Y Icimoto; Leonardo G P Ruiz; Maurício L Nogueira; Antônio S K Braz; Luiz Juliano; Maria C C da Silva
Journal:  Front Microbiol       Date:  2017-05-23       Impact factor: 5.640

2.  High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR.

Authors:  Merlin Deckers; Jörg Hofmann; Karl-Anton Kreuzer; Henrike Reinhard; Abigail Edubio; Hartmut Hengel; Sebastian Voigt; Bernhard Ehlers
Journal:  Virol J       Date:  2009-11-26       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.